Christopher A. McGinnis - 03 Mar 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Chief Financial Officer & Treasurer
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Christopher A McGinnis
Issuer symbol
GDRX
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
05 Mar 2025, 17:47:47 UTC
Previous filing
05 Feb 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Award $0 +716,479 $0.000000 716,479 03 Mar 2025 Class A Common Stock 716,479 Direct F1, F2
transaction GDRX Stock Option (Right to Buy) Award $0 +1,096,937 $0.000000 1,096,937 03 Mar 2025 Class A Common Stock 1,096,937 $4.85 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
F3 The option will vest and become exercisable as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.

Remarks:

Chief Financial Officer & Treasurer